1-4 of 4
Seppo Meri
Close
Sort by
Journal Articles

Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome

Satu Hyvärinen, Seppo Meri, T. Sakari Jokiranta
Journal: Blood
Blood (2016) 127 (22): 2701–2710.
https://doi.org/10.1182/blood-2015-11-680009
Published: 2016
Journal Articles

STAT5 Signaling Is Associated with the Outcome of Follicular and Mantle Cell Lymphoma Patients Treated with Immunochemotherapy.

Sirpa Leppä, MD, PhD, Minna Taskinen, MSci, Antti Sommarhem, MD, Erkki Elonen, MD, PhD, Matti Nykter, PhD, Outi Monni, PhD, Tuomo Timonen, MD, PhD, Sampsa Hautaniemi, PhD, Marja-Liisa Karjalainen-Lindsberg, MD, PhD, Seppo Meri, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2626.
https://doi.org/10.1182/blood.V110.11.2626.2626
Published: 2007
Journal Articles

Expression of Complement Regulatory Protein CD55 on Tumor Cells Has an Adverse Effect on the Outcome of Follicular Lymphoma Patients Treated with Immunochemotherapy

Antti Sommarhem, Sirpa Leppä, Marja-Liisa Karjalainen-Lindsberg, Seppo Meri
Journal: Blood
Blood (2007) 110 (11): 1297.
https://doi.org/10.1182/blood.V110.11.1297.1297
Published: 2007
Journal Articles

The Use of Gene-Expression Profiling to Predict Outcome of Follicular Lymphoma Patients Treated with Rituximab and Chemotherapy.

Antti Harjunpää, Matti Nykter, Outi Monni, Marja-Liisa Karjalainen-Lindsberg, Samuli Hemmer, Olli Yli-Harja, Seppo Meri, Sirpa Leppä
Journal: Blood
Blood (2004) 104 (11): 1395.
https://doi.org/10.1182/blood.V104.11.1395.1395
Published: 2004